PubMed:7565415
Annnotations
Inflammaging
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-136 | Sentence | denotes | Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors. |
| T2 | 137-371 | Sentence | denotes | CD4+ macrophages in tissues such as lung, skin, and lymph nodes, promyelocytic cells in bone marrow, and peripheral blood monocytes serve as important targets and reservoirs for human immunodeficiency virus type 1 (HIV-1) replication. |
| T3 | 372-509 | Sentence | denotes | HIV-1-infected myeloid cells are often diminished in their ability to participate in chemotaxis, phagocytosis, and intracellular killing. |
| T4 | 510-783 | Sentence | denotes | HIV-1 infection of myeloid cells can lead to the expression of surface receptors associated with cellular activation and/or differentiation that increase the responsiveness of these cells to cytokines secreted by neighboring cells as well as to bacteria or other pathogens. |
| T5 | 784-923 | Sentence | denotes | Enhancement of HIV-1 replication is related in part to increased DNA-binding activity of cellular transcription factors such as NF-kappa B. |
| T6 | 924-1101 | Sentence | denotes | NF-kappa B binds to the HIV-1 enhancer region of the long terminal repeat and contributes to the inducibility of HIV-1 gene expression in response to multiple activating agents. |
| T7 | 1102-1262 | Sentence | denotes | Phosphorylation and degradation of the cytoplasmic inhibitor I kappa B alpha are crucial regulatory events in the activation of NF-kappa B DNA-binding activity. |
| T8 | 1263-1360 | Sentence | denotes | Both N- and C-terminal residues of I kappa B alpha are required for inducer-mediated degradation. |
| T9 | 1361-1539 | Sentence | denotes | Chronic HIV-1 infection of myeloid cells leads to constitutive NF-kappa B DNA-binding activity and provides an intranuclear environment capable of perpetuating HIV-1 replication. |
| T10 | 1540-1679 | Sentence | denotes | Increased intracellular stores of latent NF-kappa B may also result in rapid inducibility of NF-kappa B-dependent cytokine gene expression. |
| T11 | 1680-1906 | Sentence | denotes | In response to secondary pathogenic infections or antigenic challenge, cytokine gene expression is rapidly induced, enhanced, and sustained over prolonged periods in HIV-1-infected myeloid cells compared with uninfected cells. |
| T12 | 1907-2018 | Sentence | denotes | Elevated levels of several inflammatory cytokines have been detected in the sera of HIV-1-infected individuals. |
| T13 | 2019-2142 | Sentence | denotes | Secretion of myeloid cell-derived cytokines may both increase virus production and contribute to AIDS-associated disorders. |
| T1 | 0-136 | Sentence | denotes | Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors. |
| T2 | 137-371 | Sentence | denotes | CD4+ macrophages in tissues such as lung, skin, and lymph nodes, promyelocytic cells in bone marrow, and peripheral blood monocytes serve as important targets and reservoirs for human immunodeficiency virus type 1 (HIV-1) replication. |
| T3 | 372-509 | Sentence | denotes | HIV-1-infected myeloid cells are often diminished in their ability to participate in chemotaxis, phagocytosis, and intracellular killing. |
| T4 | 510-783 | Sentence | denotes | HIV-1 infection of myeloid cells can lead to the expression of surface receptors associated with cellular activation and/or differentiation that increase the responsiveness of these cells to cytokines secreted by neighboring cells as well as to bacteria or other pathogens. |
| T5 | 784-923 | Sentence | denotes | Enhancement of HIV-1 replication is related in part to increased DNA-binding activity of cellular transcription factors such as NF-kappa B. |
| T6 | 924-1101 | Sentence | denotes | NF-kappa B binds to the HIV-1 enhancer region of the long terminal repeat and contributes to the inducibility of HIV-1 gene expression in response to multiple activating agents. |
| T7 | 1102-1262 | Sentence | denotes | Phosphorylation and degradation of the cytoplasmic inhibitor I kappa B alpha are crucial regulatory events in the activation of NF-kappa B DNA-binding activity. |
| T8 | 1263-1360 | Sentence | denotes | Both N- and C-terminal residues of I kappa B alpha are required for inducer-mediated degradation. |
| T9 | 1361-1539 | Sentence | denotes | Chronic HIV-1 infection of myeloid cells leads to constitutive NF-kappa B DNA-binding activity and provides an intranuclear environment capable of perpetuating HIV-1 replication. |
| T10 | 1540-1679 | Sentence | denotes | Increased intracellular stores of latent NF-kappa B may also result in rapid inducibility of NF-kappa B-dependent cytokine gene expression. |
| T11 | 1680-1906 | Sentence | denotes | In response to secondary pathogenic infections or antigenic challenge, cytokine gene expression is rapidly induced, enhanced, and sustained over prolonged periods in HIV-1-infected myeloid cells compared with uninfected cells. |
| T12 | 1907-2018 | Sentence | denotes | Elevated levels of several inflammatory cytokines have been detected in the sera of HIV-1-infected individuals. |
| T13 | 2019-2142 | Sentence | denotes | Secretion of myeloid cell-derived cytokines may both increase virus production and contribute to AIDS-associated disorders. |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 82-95 | cell_type | denotes | myeloid cells |
| T2 | 99-113 | protein | denotes | NF-kappa B/Rel |
| T3 | 114-135 | protein | denotes | transcription factors |
| T4 | 137-153 | cell_line | denotes | CD4+ macrophages |
| T5 | 202-221 | cell_type | denotes | promyelocytic cells |
| T6 | 242-268 | cell_type | denotes | peripheral blood monocytes |
| T7 | 387-400 | cell_type | denotes | myeloid cells |
| T8 | 529-542 | cell_type | denotes | myeloid cells |
| T9 | 573-590 | protein | denotes | surface receptors |
| T10 | 701-710 | protein | denotes | cytokines |
| T11 | 873-903 | protein | denotes | cellular transcription factors |
| T12 | 912-922 | protein | denotes | NF-kappa B |
| T13 | 924-934 | protein | denotes | NF-kappa B |
| T14 | 948-962 | DNA | denotes | HIV-1 enhancer |
| T15 | 977-997 | DNA | denotes | long terminal repeat |
| T16 | 1141-1162 | protein | denotes | cytoplasmic inhibitor |
| T17 | 1163-1172 | protein | denotes | I kappa B |
| T18 | 1230-1240 | protein | denotes | NF-kappa B |
| T19 | 1298-1307 | protein | denotes | I kappa B |
| T20 | 1388-1401 | cell_type | denotes | myeloid cells |
| T21 | 1424-1434 | protein | denotes | NF-kappa B |
| T22 | 1574-1591 | protein | denotes | latent NF-kappa B |
| T23 | 1633-1643 | protein | denotes | NF-kappa B |
| T24 | 1654-1662 | protein | denotes | cytokine |
| T25 | 1751-1759 | protein | denotes | cytokine |
| T26 | 1846-1874 | cell_line | denotes | HIV-1-infected myeloid cells |
| T27 | 1889-1905 | cell_type | denotes | uninfected cells |
| T28 | 1934-1956 | protein | denotes | inflammatory cytokines |
| T29 | 2032-2062 | protein | denotes | myeloid cell-derived cytokines |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 82-95 | NP | denotes | myeloid cells |
| C2 | 315-370 | NP | denotes | human immunodeficiency virus type 1 (HIV-1) replication |
| C3 | 372-400 | NP | denotes | HIV-1-infected myeloid cells |
| C4 | 425-430 | NP | denotes | their |
| C5 | 529-542 | NP | denotes | myeloid cells |
| C6 | 573-649 | NP | denotes | surface receptors associated with cellular activation and/or differentiation |
| C7 | 650-654 | NP | denotes | that |
| C8 | 686-697 | NP | denotes | these cells |
| C9 | 799-816 | NP | denotes | HIV-1 replication |
| C10 | 912-922 | NP | denotes | NF-kappa B |
| C11 | 924-934 | NP | denotes | NF-kappa B |
| C12 | 1137-1178 | NP | denotes | the cytoplasmic inhibitor I kappa B alpha |
| C13 | 1298-1313 | NP | denotes | I kappa B alpha |
| C14 | 1388-1401 | NP | denotes | myeloid cells |
| C15 | 1521-1538 | NP | denotes | HIV-1 replication |
| C16 | 1633-1678 | NP | denotes | NF-kappa B-dependent cytokine gene expression |
| C17 | 1751-1775 | NP | denotes | cytokine gene expression |
| C18 | 1846-1874 | NP | denotes | HIV-1-infected myeloid cells |
| R1 | C4 | C3 | coref-pron | their,HIV-1-infected myeloid cells |
| R2 | C5 | C1 | coref-ident | myeloid cells,myeloid cells |
| R3 | C7 | C6 | coref-relat | that,surface receptors associated with cellular activation and/or differentiation |
| R4 | C8 | C5 | coref-ident | these cells,myeloid cells |
| R5 | C9 | C2 | coref-ident | HIV-1 replication,human immunodeficiency virus type 1 (HIV-1) replication |
| R6 | C11 | C10 | coref-ident | NF-kappa B,NF-kappa B |
| R7 | C13 | C12 | coref-ident | I kappa B alpha,the cytoplasmic inhibitor I kappa B alpha |
| R8 | C14 | C5 | coref-ident | myeloid cells,myeloid cells |
| R9 | C15 | C9 | coref-ident | HIV-1 replication,HIV-1 replication |
| R10 | C17 | C16 | coref-ident | cytokine gene expression,NF-kappa B-dependent cytokine gene expression |
| R11 | C18 | C3 | coref-ident | HIV-1-infected myeloid cells,HIV-1-infected myeloid cells |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-136 | Sentence | denotes | Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors. |
| S2 | 137-371 | Sentence | denotes | CD4+ macrophages in tissues such as lung, skin, and lymph nodes, promyelocytic cells in bone marrow, and peripheral blood monocytes serve as important targets and reservoirs for human immunodeficiency virus type 1 (HIV-1) replication. |
| S3 | 372-509 | Sentence | denotes | HIV-1-infected myeloid cells are often diminished in their ability to participate in chemotaxis, phagocytosis, and intracellular killing. |
| S4 | 510-783 | Sentence | denotes | HIV-1 infection of myeloid cells can lead to the expression of surface receptors associated with cellular activation and/or differentiation that increase the responsiveness of these cells to cytokines secreted by neighboring cells as well as to bacteria or other pathogens. |
| S5 | 784-923 | Sentence | denotes | Enhancement of HIV-1 replication is related in part to increased DNA-binding activity of cellular transcription factors such as NF-kappa B. |
| S6 | 924-1101 | Sentence | denotes | NF-kappa B binds to the HIV-1 enhancer region of the long terminal repeat and contributes to the inducibility of HIV-1 gene expression in response to multiple activating agents. |
| S7 | 1102-1262 | Sentence | denotes | Phosphorylation and degradation of the cytoplasmic inhibitor I kappa B alpha are crucial regulatory events in the activation of NF-kappa B DNA-binding activity. |
| S8 | 1263-1360 | Sentence | denotes | Both N- and C-terminal residues of I kappa B alpha are required for inducer-mediated degradation. |
| S9 | 1361-1539 | Sentence | denotes | Chronic HIV-1 infection of myeloid cells leads to constitutive NF-kappa B DNA-binding activity and provides an intranuclear environment capable of perpetuating HIV-1 replication. |
| S10 | 1540-1679 | Sentence | denotes | Increased intracellular stores of latent NF-kappa B may also result in rapid inducibility of NF-kappa B-dependent cytokine gene expression. |
| S11 | 1680-1906 | Sentence | denotes | In response to secondary pathogenic infections or antigenic challenge, cytokine gene expression is rapidly induced, enhanced, and sustained over prolonged periods in HIV-1-infected myeloid cells compared with uninfected cells. |
| S12 | 1907-2018 | Sentence | denotes | Elevated levels of several inflammatory cytokines have been detected in the sera of HIV-1-infected individuals. |
| S13 | 2019-2142 | Sentence | denotes | Secretion of myeloid cell-derived cytokines may both increase virus production and contribute to AIDS-associated disorders. |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 14-49 | virus | denotes | human immunodeficiency virus type 1 |
| T2 | 63-78 | other_name | denotes | gene expression |
| T3 | 82-95 | cell_type | denotes | myeloid cells |
| T4 | 99-109 | protein_molecule | denotes | NF-kappa B |
| T5 | 114-135 | protein_family_or_group | denotes | transcription factors |
| T6 | 137-153 | cell_line | denotes | CD4+ macrophages |
| T7 | 173-177 | body_part | denotes | lung |
| T8 | 179-183 | body_part | denotes | skin |
| T9 | 189-200 | body_part | denotes | lymph nodes |
| T10 | 202-221 | cell_type | denotes | promyelocytic cells |
| T11 | 225-236 | tissue | denotes | bone marrow |
| T12 | 242-268 | cell_type | denotes | peripheral blood monocytes |
| T13 | 315-350 | virus | denotes | human immunodeficiency virus type 1 |
| T14 | 352-357 | virus | denotes | HIV-1 |
| T15 | 372-377 | virus | denotes | HIV-1 |
| T16 | 387-400 | cell_type | denotes | myeloid cells |
| T17 | 457-467 | other_name | denotes | chemotaxis |
| T18 | 469-481 | other_name | denotes | phagocytosis |
| T19 | 487-508 | other_name | denotes | intracellular killing |
| T20 | 510-515 | virus | denotes | HIV-1 |
| T21 | 529-542 | cell_type | denotes | myeloid cells |
| T22 | 573-590 | protein_family_or_group | denotes | surface receptors |
| T23 | 607-626 | other_name | denotes | cellular activation |
| T24 | 634-649 | other_name | denotes | differentiation |
| T25 | 701-710 | protein_family_or_group | denotes | cytokines |
| T26 | 755-763 | mono_cell | denotes | bacteria |
| T27 | 799-804 | virus | denotes | HIV-1 |
| T28 | 849-869 | other_name | denotes | DNA-binding activity |
| T29 | 873-881 | protein_family_or_group | denotes | cellular |
| T30 | 882-903 | protein_family_or_group | denotes | transcription factors |
| T31 | 912-922 | protein_molecule | denotes | NF-kappa B |
| T32 | 924-934 | protein_molecule | denotes | NF-kappa B |
| T33 | 948-953 | virus | denotes | HIV-1 |
| T34 | 977-997 | DNA_domain_or_region | denotes | long terminal repeat |
| T35 | 1037-1042 | virus | denotes | HIV-1 |
| T36 | 1043-1058 | other_name | denotes | gene expression |
| T37 | 1102-1117 | other_name | denotes | Phosphorylation |
| T38 | 1122-1133 | other_name | denotes | degradation |
| T39 | 1141-1162 | protein_family_or_group | denotes | cytoplasmic inhibitor |
| T40 | 1163-1172 | protein_molecule | denotes | I kappa B |
| T41 | 1230-1240 | protein_molecule | denotes | NF-kappa B |
| T42 | 1241-1261 | other_name | denotes | DNA-binding activity |
| T43 | 1298-1307 | protein_molecule | denotes | I kappa B |
| T44 | 1331-1359 | other_name | denotes | inducer-mediated degradation |
| T45 | 1369-1374 | virus | denotes | HIV-1 |
| T46 | 1388-1401 | cell_type | denotes | myeloid cells |
| T47 | 1424-1434 | protein_molecule | denotes | NF-kappa B |
| T48 | 1435-1455 | other_name | denotes | DNA-binding activity |
| T49 | 1472-1496 | other_name | denotes | intranuclear environment |
| T50 | 1521-1526 | virus | denotes | HIV-1 |
| T51 | 1550-1570 | other_name | denotes | intracellular stores |
| T52 | 1574-1580 | protein_molecule | denotes | latent |
| T53 | 1581-1591 | protein_molecule | denotes | NF-kappa B |
| T54 | 1633-1643 | protein_molecule | denotes | NF-kappa B |
| T55 | 1654-1662 | protein_family_or_group | denotes | cytokine |
| T56 | 1663-1678 | other_name | denotes | gene expression |
| T57 | 1751-1759 | protein_family_or_group | denotes | cytokine |
| T58 | 1760-1775 | other_name | denotes | gene expression |
| T59 | 1846-1851 | virus | denotes | HIV-1 |
| T60 | 1861-1874 | cell_type | denotes | myeloid cells |
| T61 | 1889-1905 | cell_type | denotes | uninfected cells |
| T62 | 1934-1956 | protein_family_or_group | denotes | inflammatory cytokines |
| T63 | 1991-1996 | virus | denotes | HIV-1 |
| T64 | 2032-2052 | protein_family_or_group | denotes | myeloid cell-derived |
| T65 | 2053-2062 | protein_family_or_group | denotes | cytokines |
| T66 | 2081-2097 | other_name | denotes | virus production |
| T67 | 2116-2141 | other_name | denotes | AIDS-associated disorders |